Table 1.
Panel | Comparison | Marker Type |
Assay Platform |
Sample Size |
Markers in Panel | Sensitivity / Specificity |
---|---|---|---|---|---|---|
22 Gene Panel8 | Ischemic Stroke vs Control | RNA, PBMCs | Microarray, Affymetrix U133A | 40 | ADM, APLP2, BST1, C1QR1, CD14, CD163, CD36, CSPG2, CYBB, DUSP1, ENTPD1, ETS2, FCGR1A, FLJ22662, FOS, IL13RA1, KIAA0146, LTA4H, NPL, PILRA, TLR2 | 78% / 80% |
18 Gene Panel9 | Ischemic Stroke vs Control | RNA, Whole Blood | Microarray, Affymetrix U133 Plus 2.0 | 60 | ARG1, BCL6, CA4, CKAP4, ETS-2, HIST2H2AA, HOX1.11, F5, FPR1, LY96, MMP9, NPL, PYGL, RNASE2, S100A9, S100A12, S100P, SLC16A6 | 89% / 100% |
9 Gene Panel10 | Ischemic Stroke vs Control | RNA, Whole Blood | Microarray, Illumina HumanRef-8v2 bead chip | 64 | ARG1, CA4, CCR7, CSPG2, IQGAP1, LY96, MMP9, ORM1, S100A12 | --- |
18 Gene Panel11 | Ischemic Stroke vs Control | RNA, Whole Blood | Microarray, Affymetrix U133 Plus 2.0 | 237 | ARG1, BCL6, CA4, CKAP4, ETS-2, HIST2H2AA, HOX1.11, F5, FPR1, LY96, MMP9, NPL, PYGL, RNASE2, S100A9, S100A12, S100P, SLC16A6 | 93% / 95% |
6 Protein Panel12 | Ischemic + Hemorrhagic Stroke vs Control | Protein, Plasma | ELISA | 1005 | Caspase-3, Chimerin, D-dimer, MMP-9, Secretagogin, sRAGE | 17%/98% |
5 Protein Panel13 | Ischemic + Hemorrhagic Stroke vs Control | Protein, Plasma | ELISA | 437 | BNGF, MCP-1, MMP-9, S100B, vWF | 92%/93% |
4 Protein Panel14 | Ischemic + Hemorrhagic Stroke vs Control | Protein, Plasma | ELISA | 946 +343 |
BNP, D-dimer, MMP9, S100B | 86%/37% |
4 Protein Panel15 | Ischemic Stroke vs Control | Protein, Plasma | ELISA | 222 | MMP-9, S100B, VCAM, vWF | 90%/90% |
4 Protein Panel16 | Ischemic Stroke vs Control | Protein, Whole blood | Immunoassay | 155 | BNP, D-dimer, MMP-9, S100B | 73%/72% |
5 Protein Panel17 | Ischemic + Hemorrhagic Stroke vs Control | Protein, Plasma | Immunoassay | 130 | Eotaxin, EGFR, S100A12, Metalloproteinase inhibitor-4, Prolactin | 90%/84% |
2 Protein Panel18 | Cardioembolic vs NonCardioembolic stroke | Protein, Plasma | ELISA | 707 | D-dimer, BNP | 87%/85% |
40 Gene Panel19 | Large vessel vs Cardioembolic Stroke | RNA, Whole Blood | Microarray, Affymetrix U133 Plus 2.0 | 99 | ADAMTSL4, AP3S2, ARHGEF12, ARHGEF5, BANK1, C16orf68, C19orf28, CD46, CHURC1, CLEC18A, COL13A1, EBF1, ENPP2, EXT2, FCRL1, FLJ40125, GRM5, GSTK1, HLA-DOA, IRF6, LHFP, LHFP, LOC284751, LRRC37A3, OOEP, P2RX5, PIK3C2B, PTPN20A, TFDP1, TMEM19, TSKS, ZNF185, ZNF254 | 100%/96% |
41 Gene Panel20 | Lacunar vs Non-Lacunar Stroke | RNA, Whole Blood | Microarray, Affymetrix U133 Plus 2.0 Microarray | 131 | ALS2CR11, C18orf49, CALM1, CCDC114, CCDC78, CCL2, CCL3, CHML, FAM179A, FAM70B, FLJ13773, GBP4, GTF2H2, HLA-DQA1, HLA-DRB4, IL8, LAG3, LAIR2, LGR6, LRRC8B, MPZL3, OASL, PDXDC1, PROCR, PRSS23, QKI, RASEF, RUNX3, SCAND2, STK4, STX7, TGFBR3, TSEN54, TTC12, UBA7, UGCG. UTS2, VAPA | >90%/90% |